Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstraße 11, 80937 Munich, Germany.
Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstraße 11, 80937 Munich, Germany; Walther Straub Institute of Pharmacology and Toxicology, University of Munich, Goethestr. 33, 80336 Munich, Germany.
Toxicol Lett. 2018 Sep 1;293:38-44. doi: 10.1016/j.toxlet.2017.08.014. Epub 2017 Aug 18.
MicroRNAs (miRNAs) are responsible for post-transcriptional control of protein expression. Numerous miRNAs have been identified to be responsible for the resistance of tumor cells to cytostatic drugs. Possibly, the same miRNAs also play a role in the sulfur mustard (SM)-resistance of the keratinocyte cell line HaCaT/SM as alkylating cytostatics exhibit similar cytotoxic effects as SM.
Basal expression levels of 1920 miRNAs in total were analyzed in HaCaT/SM compared to the origin human keratinocyte cell line HaCaT. The effect for selected miRNAs on cell survival was analyzed using antagomirs for ectopic miRNA level decrease or miRNA mimics for increase. Cell survival was calculated as SM dose-dependent-curves.
Out of 1920 miRNAs analyzed, 49 were significantly up- and 29 were significantly downregulated in HaCaT/SM when compared to HaCaT controls. Out of these, 36 could be grouped in miRNA families. Most of the 15 miRNA family members showed either a common increase or decrease. Only the members of miR-10, miR-154, miR-430 and miR-548 family showed an inconsistent picture. The ectopic increase of miR-181 in HaCaT/SM had a positive effect on cell survival in the presence of SM.
In summary, the extensive differences in miRNA expression pattern between these cell lines indicate that specific miRNAs may play a role in the resistance mechanism against sulfur mustard. The miR-125b-2 and miR-181b alone are not responsible for the resistance development against SM, but an ectopic increase of miR-181 even enhances the SM resistance of HaCaT/SM. Improving the resistance in normal keratinocytes by treatment with either both miRNAs together or a different combination might be used as an initial step in development of an innovative new drug or prophylactic agent against SM.
微小 RNA(miRNA)负责蛋白质表达的转录后调控。许多 miRNA 被鉴定为导致肿瘤细胞对细胞抑制剂耐药的原因。可能,相同的 miRNA 也在角质形成细胞系 HaCaT/SM 对硫芥(SM)的耐药性中发挥作用,因为烷化细胞抑制剂表现出与 SM 相似的细胞毒性作用。
在 HaCaT/SM 中与原始人角质形成细胞系 HaCaT 相比,分析了总共 1920 个 miRNA 的基础表达水平。使用反义寡核苷酸降低异位 miRNA 水平或 miRNA 模拟物增加来分析选定 miRNA 对细胞存活的影响。细胞存活率作为 SM 剂量依赖性曲线计算。
在分析的 1920 个 miRNA 中,与 HaCaT 对照相比,HaCaT/SM 中有 49 个明显上调,29 个明显下调。其中,36 个可以归类为 miRNA 家族。大多数 miRNA 家族成员表现出共同的增加或减少。只有 miR-10、miR-154、miR-430 和 miR-548 家族的成员表现出不一致的情况。HaCaT/SM 中 miR-181 的异位增加对 SM 存在时的细胞存活有积极影响。
总之,这些细胞系之间 miRNA 表达模式的广泛差异表明,特定的 miRNA 可能在抵抗 SM 的机制中发挥作用。miR-125b-2 和 miR-181b 单独不能对 SM 耐药性的发展负责,但 miR-181 的异位增加甚至增强了 HaCaT/SM 的 SM 耐药性。通过用这两种 miRNA 一起或不同的组合处理来改善正常角质形成细胞的耐药性,可能作为开发针对 SM 的创新新药或预防性药物的初始步骤。